News Flash: The New York Times Covers Colombian Family, API
In a sign that prevention trials are shifting from “should do” to “will do,” academic and industry groups are getting serious about prevention trials...
6352 RESULTS
Sort By:
In a sign that prevention trials are shifting from “should do” to “will do,” academic and industry groups are getting serious about prevention trials...
Two recent papers provide more information about how motor neuron disease progresses in rodents...
The blend of AD and PD features in dementia with Lewy bodies (DLB) make it one of the most challenging neurodegenerative disorders to study...
Clinicians have long puzzled over the heterogeneity of Alzheimer disease symptoms...
Like alchemists aiming to turn base metals into gold, scientists are striving to convert one cell type into another—with a little more success...
Though some 55,000 people have received deep-brain stimulation, there is still plenty of room to improve the process...
Deep-brain stimulation (DBS) is not just for shakes and trembles any more...
With a few electrodes, surgeons can often still the embarrassing tremors and alleviate the painful muscle cramps that come with Parkinson disease...
In this series, ARF takes stock of deep-brain stimulation after more than a decade of life-altering procedures, In deep brain stimulation, surgeons implant wires into the brain and hook them up to a pacemaker-like stimulator implanted in the chest, which
Although most cases of amyotrophic lateral sclerosis have no evidence of inheritance, scientists are finding valuable clues to the disease among familial cases...
In this series, ARF takes stock of deep-brain stimulation after more than a decade of life-altering procedures...
Notch, that pesky “other” γ-secretase substrate, mediates adult neurogenesis defects attributed to presenilin-1 (PS1) mutations...
Scientists propose that Auguste Deter, the first identified Alzheimer disease patient, carried the N141I presenilin-2 mutation...
Rebounds leave basketball fans on the edge of their seats. They can also leave drug developers with bated breath—rebounds of the Aβ kind, that is...
By some measures, ApoE found its first companions in 2009 when scientists reported three additional genes robustly linked to late-onset Alzheimer disease...